Authors: PRESS OW LEBLANC M OROURKE TJ GAGNET S CHAPMAN RA BALCERZAK SP FISHER RI

Citation: Ow. Press et al., PHASE-II TRIAL OF PACLITAXEL BY 24-HOUR CONTINUOUS-INFUSION FOR RELAPSED NON-HODGKINS-LYMPHOMAS - SOUTHWEST-ONCOLOGY-GROUP TRIAL-9246, Journal of clinical oncology, 16(2), 1998, pp. 574-578

Authors: BURRIS HA RAYMOND E AWADA A KUHN JG OROURKE TJ BRENTZEL J LYNCH W KING SYP BROWN TD VONHOFF DD

Citation: Ha. Burris et al., PHARMACOKINETIC AND PHASE-I STUDIES OF BREQUINAR (DUP-785, NSC-368390) IN COMBINATION WITH CISPLATIN IN PATIENTS WITH ADVANCED MALIGNANCIES, Investigational new drugs, 16(1), 1998, pp. 19-27

Authors: FURGERSON JL VUKELJA SJ BAKER WJ OROURKE TJ

Citation: Jl. Furgerson et al., ACUTE MYELOID-LEUKEMIA EVOLVING FROM ESSENTIAL THROMBOCYTHEMIA IN 2 PATIENTS TREATED WITH HYDROXYUREA, American journal of hematology, 51(2), 1996, pp. 137-140

Authors: OROURKE TJ BROWN TD HAVLIN K KUHN JG CRAIG JB BURRIS HA SATTERLEE WG TARASSOFF PG VONHOFF DD

Citation: Tj. Orourke et al., PHASE-I CLINICAL-TRIAL OF GEMCITABINE GIVEN AS AN INTRAVENOUS BOLUS ON 5 CONSECUTIVE DAYS, European journal of cancer, 30A(3), 1994, pp. 417-419

Authors: OROURKE TJ WEISS GR NEW P BURRIS HA RODRIGUEZ G ECKHARDT J HARDY J KUHN JG FIELDS S CLARK GM VONHOFF DD

Citation: Tj. Orourke et al., PHASE-I CLINICAL-TRIAL OF ORMAPLATIN (TETRAPLATIN, NSC-363812), Anti-cancer drugs, 5(5), 1994, pp. 520-526

Authors: BROWN TD OROURKE TJ KUHN JG CRAIG JB HAVLIN K BURRIS HA CAGNOLA J HAMILTON JM GRINDEY GB SATTERLEE WG VONHOFF DD

Citation: Td. Brown et al., PHASE-I TRIAL OF SULOFENUR (LY186641) GIVEN ORALLY ON A DAILY X 21 SCHEDULE, Anti-cancer drugs, 5(2), 1994, pp. 151-159